Core Viewpoint - The recent surge in procurement of etching equipment by universities reflects China's accelerated efforts in semiconductor foundational research, talent cultivation, and domestic substitution [2]. Group 1: Procurement Trends - Recent procurement data from July 1 to July 14 indicates a concentrated purchasing activity of etching equipment by various universities, highlighting a strategic move towards enhancing domestic semiconductor capabilities [2]. - Specific procurement announcements from institutions like Fudan University and Tianjin University explicitly state that only domestic products will be accepted, aiming to support local equipment manufacturers [2]. Group 2: Etching Process Overview - Etching is a critical step in semiconductor manufacturing, involving the selective removal of unwanted materials from the silicon wafer surface using chemical or physical methods [2]. - The etching process is categorized into wet etching and dry etching, each serving distinct purposes in the fabrication of semiconductor devices [2]. Group 3: Procurement Details - A detailed table lists various procurement projects, including: - Shenzhen University purchasing an inductively coupled plasma etching system for approximately 950,000 yuan [3]. - Tianjin University acquiring an inductively coupled plasma etching machine for about 1,180,000 yuan [3]. - Harbin Institute of Technology's procurement of a bias-assisted ion etching system for 1,980,000 yuan [3]. - Fudan University’s purchase of a deep silicon etching machine for 4,795,000 yuan [3]. - The procurement activities indicate a significant investment in advanced etching technologies, which are essential for the development of semiconductor devices [3].

Core Viewpoint - Suzhou Langsheng Scientific Instrument Co., Ltd. has emerged as a significant player in the field of spectroscopic instruments through technological innovation, starting with handheld X-ray fluorescence spectrometers and expanding into various portable analytical instruments widely used in environmental protection, petrochemicals, and scientific research, thereby promoting the development of domestic scientific instruments [2][5]. Group 1: Company Development - Founded in 2012, Langsheng initially targeted the market with handheld X-ray fluorescence spectrometers (XRF) amidst a landscape dominated by international giants [5]. - The company adopted a "low-key and pragmatic" craftsmanship spirit, focusing on breakthroughs in specific scenarios due to the technological gap in core algorithms and detectors in domestic instruments [5]. - In 2014, Langsheng developed the Super-FP algorithm, enhancing the precision of XRF quantitative analysis with advanced mathematical models [5]. - The year 2018 marked the launch of a portable oil analysis instrument that quickly and accurately detects sulfur content in oil, gaining widespread recognition in the maritime system [5][6]. Group 2: Technological Innovations - In 2021, Langsheng introduced the first domestic portable X-ray diffraction instrument, "YingSHINE," filling a gap in the domestic market and enhancing its technical advantages in X-ray crystallography [6]. - The company is set to launch the first domestic portable total reflection X-ray fluorescence spectrometer (TXRF) in 2024, marking a significant breakthrough in trace element analysis technology [6]. - Over the years, Langsheng has developed multiple products, including portable X-ray fluorescence-Raman combined instruments and desktop X-ray diffraction instruments, which have received nominations for industry awards, reflecting their trust and recognition in the scientific instrument sector [6][13]. Group 3: Strategic Transition - Langsheng is transitioning from a device manufacturer to a multi-technology platform solution provider, driven by continuous technological investment and team expansion, with the team size exceeding 100 by 2025 [13]. - The company has adopted a differentiated path of "scene-defined technology" rather than merely pursuing parameter replacement, focusing on specific application areas such as metal materials, environmental protection, and petrochemicals [14]. - Langsheng's technological achievements have been deeply integrated into environmental law enforcement, industrial quality control, and scientific innovation, continuously driving improvements in detection efficiency [14].

Core Viewpoint - The article highlights the significant advancements in mass spectrometry technology in the first half of 2025, showcasing a series of groundbreaking new products that cater to diverse needs from basic analysis to high-end research [1][2]. Product Overview - A variety of new mass spectrometry products were launched in the first half of 2025, with notable entries from major companies such as Thermo Fisher, Bruker, Waters, and SCIEX, reflecting the ongoing innovation in the field [5][6]. - Key products include: - Thermo Scientific IM Orbitrap IM Zoom and Orbitrap Excedion Pro, which enhance sensitivity and throughput for complex biological molecule analysis [6][7]. - Bruker's timsOmni, timsUltra AIP, and timsMetabo, which focus on protein and metabolomics with advanced ion mobility techniques [6][8]. - SCIEX's ZenoTOF 8600, which integrates advanced detection technologies for research and precision medicine applications [7][8]. - Waters' Xevo TQ Absolute XR, designed for ultra-sensitive detection in PFAS and drug quantification [7][8]. Trends in Innovation - The new products emphasize higher sensitivity and throughput, smarter data acquisition and analysis, stronger multi-omics integration capabilities, and broader application coverage [9]. - Domestic mass spectrometry companies have achieved a near "50-50" balance with imported products in terms of new product launches, indicating significant progress in local technology and innovation [11][12]. Domestic Product Highlights - Domestic companies like Anhui Wanyi Technology and Shandong Yingsheng Biotech have introduced several new products, including the TQ9200 series and fully automated systems, showcasing advancements in automation and miniaturization [12][13]. - The GBI LINE-MS2600 from BGI highlights improvements in hardware design and intelligence, while Zhengzhou Antu Bio has launched multiple liquid chromatography tandem mass spectrometry systems [14][15]. Regulatory Progress - In the first half of 2025, three domestic medical mass spectrometry products received registration certificates, with a 55% year-on-year increase in approved mass spectrometry reagent kits and standards, indicating a growing trend in the medical application of mass spectrometry [16][17]. Market Dynamics - The article concludes that both imported and domestic manufacturers are focusing on integrating mass spectrometry technology into clinical diagnostics, drug analysis, and environmental monitoring, reshaping the landscape of the scientific instrument industry [18].

导读： 2025年，丹东百特迎来成立三十周年的辉煌时刻! 为感恩全球用户的支持与陪伴，我们将于7月21日-22日隆重举办线上庆典活动，携手仪器信息网全程直 播。诚邀您云端相聚，共溯百特三十载科技征程。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 2 0 2 5年，丹东百特迎来 成立三十周年的辉煌时刻! 仪器信息网将携手丹东 百特 ，于 7月2 1日- 2 2日 隆重举办线上丹东百特三十周年庆典活 动，并在仪器信息网平台全程直播。 诚邀您云端相聚，共溯百特三十载科技征程，见证中国颗粒测试领域的"智造"传奇! 报名链接： 点击报名 报名二维码 | 10:00 欢迎致辞 | 丹东百特董事长兼总经理 董青云 | | --- | --- | | 10:20 新品揭幕 | | | | BeNano 180 Zeta Max 纳米粒度及 Zeta电位分析仪 | | | BeSEC 光散射检测器 | | | Bettersize2600Plus激光粒度分析仪 | | | BeVision D3动态图像粒度粒形分析仪 | | 10:30 百特新一代动态图 ...

Core Insights - Tsinghua University has announced 28 procurement intentions for scientific instruments, with a total budget of 213 million yuan, expected to be executed between June and August 2025 [1][2]. Instrument Procurement Summary - The procurement includes various advanced instruments such as: - Infrared Spectrometer - Molecular Interaction Analyzer - Closed-loop Low-temperature System - Customized Organ-like Microenvironment Simulation System - Real-time Cell Function and Single-cell Behavior Analysis System - High-resolution Spatial Omics Analyzer - Laser Spectral Confocal Microscope [2][3]. Detailed Procurement List - The detailed budget allocation for specific instruments includes: - Closed-loop Low-temperature System: 1.92 million yuan - Real-time Cell Function and Single-cell Behavior Analysis System: 2.6 million yuan - Customized Organ-like Microenvironment Simulation System: 2.6 million yuan - High-resolution Spatial Omics Analyzer: 4.8 million yuan - Laser Spectral Confocal Microscope: 2.6 million yuan - Molecular Interaction Analyzer: 4 million yuan - Infrared Spectrometer: 1 million yuan [4][5][6].

Core Viewpoint - The strategic partnership between Optoseeker Biotech and BioMap aims to revolutionize the development of innovative antibody therapies by integrating high-throughput cell screening capabilities with advanced AI systems, thereby accelerating drug discovery processes [2][3]. Group 1: Partnership Details - The collaboration focuses on combining Optoseeker's proprietary OptoBot series, which excels in high-throughput and high-precision single-cell functional screening, with BioMap's AI-driven capabilities in life sciences [2][3]. - The goal is to create a seamless workflow that can identify promising antibody candidates with unprecedented speed and accuracy, addressing critical bottlenecks in drug development [2][3]. Group 2: Technology Overview - The OptoBot series utilizes advanced Optoelectronic Tweezers (OET) technology to rapidly separate, culture, and analyze thousands of antibody-secreting plasma cells simultaneously, generating vast amounts of high-quality functional data [3]. - BioMap's AI system, built on its proprietary life sciences foundational model, is designed to enhance tasks such as task planning, mapping, protein function prediction, and candidate selection [3]. Group 3: Company Profiles - Optoseeker Biotech is dedicated to developing cutting-edge life science instruments to accelerate biological research and development, with a focus on high-throughput single-cell analysis and automation [4]. - BioMap is a pioneer in foundational models for life sciences, boasting a 210 billion parameter biological language model that decodes the underlying principles of genomes, proteins, cells, and biological systems, significantly reducing reliance on traditional experimental models [5].

导读： 近日，内蒙古科技大学发布多批政府采购意向，仪器信息网特对其中的仪器设备品目进行梳理，统计出2项仪器设备采购意 向，预算总额达1.22亿元。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日， 内蒙古科技大学发布 2 项仪器设备采购意向，预算总额 1 . 2 2 亿 元，涉及流式细胞仪（分选）、凝胶成像仪 、 超高分辨率激光扫描设备、高分辨率活细胞显微成像系统 等，预计采购时间为2 0 2 5 年 3~8 月。 内蒙古科技大学 2 0 2 5 年 3 ~ 8 月仪器设备采购 意向汇总表 | | | | 采 | | --- | --- | --- | --- | | 采购 | 需求概况 | 预算 | 购 | | 项目 | | 万元 | 时 | | | | | 间 | | 学 | | | | | 科、 | | | | | 专业 | | | | | 建 | | | | | 设， | | | | | 重点 | | | | | 实验 | | | | | 室建 | | | 202 | | 设， | 采购内容:教学仪器 采购数量:30.0000 ...

Core Viewpoint - Yilit Technology has established itself as a leader in the domestic liquid chromatography industry with a 95% localization rate and over 18,000 units sold, driving the process of domestic substitution [2][12]. Group 1: Company Development - Yilit Technology, founded over 30 years ago, has consistently maintained its leading position in the liquid chromatography sector through continuous innovation and strategic expansion [2][4]. - The company has recently relocated to a new facility in Suzhou, which has more than doubled its operational space and increased its workforce from 20 to nearly 100 employees, enhancing its production capacity and R&D capabilities [6][10]. Group 2: Technological Advancements - Yilit has achieved a 95% localization rate for core components, establishing a significant technological barrier and ensuring full-chain autonomy from hardware to software [7][9]. - The EClassical 3200L liquid chromatography instrument features self-developed direct drive pump technology, capable of withstanding pressures up to 130 MPa, making it suitable for clinical and pharmaceutical applications [9][12]. Group 3: Market Position and Customer Engagement - The company has sold over 18,000 instruments and more than 200,000 chromatography columns, serving over 15,000 clients across various sectors, including petrochemicals, biomedicine, and food safety [10][11]. - Yilit has developed an online HPLC spectrum library with nearly 1,000 verified spectra, aligning with the latest pharmacopoeia standards to enhance user experience and efficiency in experimental design [10][12]. Group 4: Future Outlook - Yilit plans to continue its focus on technological innovation and ecosystem development, aiming to expand its product offerings and international channels while collaborating with renowned domestic and international enterprises [13].

Core Viewpoint - The article highlights the significant growth in China's high-tech product exports, particularly in the instrumentation sector, which has shown a robust performance in the international market due to increased R&D investment and favorable conditions from initiatives like the Belt and Road [3][4]. Group 1: Export Growth - In the first half of 2025, China's instrumentation exports grew by 14.7%, continuing a trend of double-digit growth for nine consecutive months [2][3]. - The total export value of scientific instruments in 2024 is projected to be $5.57 billion, reflecting a year-on-year increase of 2.71% [3]. Group 2: Industry Development - The growth in exports is attributed to the continuous enhancement of product technology and quality within China's instrumentation industry, leading to greater international recognition [3]. - Notable domestic companies such as Guoyi Quantum, Junzheng Technology, BGI, United Imaging, and Prism Tech have successfully penetrated emerging overseas markets with competitive pricing and high-quality products [3]. Group 3: Economic Context - The Deputy Director of the General Administration of Customs, Wang Lingjun, emphasized that despite a complex global environment, China's foreign trade has shown resilience, maintaining growth in both scale and quality [3].

Core Viewpoint - The article discusses the "Action Plan" aimed at accelerating the integration of artificial intelligence (AI) into scientific research in Beijing, with a focus on developing high-quality scientific instruments and fostering innovation in various fields [2][4][7]. Group 1: Development Goals - By 2027, the plan aims to leverage Beijing's AI innovation advantages to establish new pathways for scientific research, focusing on foundational scientific issues and enhancing the application of AI across multiple fields [8]. - The initiative includes the construction of at least 10 high-quality scientific databases to support AI applications in various research areas, targeting over 10 million users [8]. Group 2: Key Tasks - The plan emphasizes critical technology breakthroughs, including foundational theoretical research in AI, the development of a universal scientific foundational model, and new generation scientific computing simulation software [9][10][11]. - Infrastructure development is a priority, with goals to create an open scientific data platform and a collaborative computing power platform to enhance research efficiency [12][13]. Group 3: Application Acceleration - The plan promotes the use of AI in basic scientific research, medical health innovation, and new materials development, aiming to enhance research efficiency and discovery processes [15][16][17]. - Specific focus is placed on empowering high-end scientific instruments through AI, encouraging collaboration between universities, research institutions, and enterprises to develop advanced scientific equipment [18]. Group 4: Innovation Ecosystem - The initiative aims to build a public service innovation platform for scientific intelligence, attract and cultivate innovative talent, and establish a multi-channel investment and financing service system [20][21][22]. - It also seeks to create a competitive scientific intelligence industry cluster and promote international cooperation and open-source ecosystems [23][24][25].